VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today ...
Recent advances in feature selection methods for breast cancer recurrence prediction: A systematic review. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
VANCOUVER, British Columbia, September 23, 2025--(BUSINESS WIRE)--Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results